Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004400053 | SCV004887709 | uncertain significance | not specified | 2023-12-18 | criteria provided, single submitter | clinical testing | The c.779T>G (p.L260W) alteration is located in exon 5 (coding exon 4) of the IFI44L gene. This alteration results from a T to G substitution at nucleotide position 779, causing the leucine (L) at amino acid position 260 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |